Originally trained as a Zoologist, Graham studied statistics and experimental design at Imperial College, London, before joining ICI as a research scientist with specific responsibility for field trials and statistics liaison.
Graham joined the Pharmaceutical Industry in 1982 where he spent 20 years in sales and marketing during which time he was head of the Pharmaceuticals division for Roche UK and Strategic Planning Director for Astra Pharmaceuticals; in which capacity he gained practical working experience in the world’s major pharmaceutical markets, including both the US and Japan. This experience led to an interest in healthcare reform, a subject on which he has published a number of articles and booklets.
Graham gained his PhD in “Competitive Strategy in the Pharmaceutical Industry” from Cranfield University. A member of the Economics and Strategy group at Aston University in Birmingham for 15 years Graham now actively researches the measurement and implications of strategic choice on corporate valuation, competitive position and return on investment, primarily, but not exclusively, within the Pharmaceutical and Healthcare industries. Research tempered by practical consulting experience gained in assisting a variety of companies to build value based strategies, measure their promotional effects, calculate return on investment and make rational strategic choices.
Graham’s main research interests centre upon strategic groups and how to measure strategy with the measurement of ROI on strategic and promotional activities a particular speciality. In 2012 Graham won the West Midlands Medilink Award for work with Kimal Plc and in 2013 the industry award (BOBI) for commercial analysis/SFE for work with MSD.
Key current interests are the optimal choice of promotional investment, the measurement of adherence and advanced segmentation techniques.